Mary Nwokedi
Daniel Lucien BÜHR
Daniel Lucien Bühr joined LALIVE in 2011 and is based in our Zurich office. His main areas of practice are regulatory and banking law and white-collar crime and compliance, principally focusing on investigations, litigation, ESG reporting, governance and risk and compliance management. He also manages complex cross-border legal and compliance projects and monitors corporate compliance remediation projects.
Daniel L. Bühr is a founding member of the International Academy of Financial Crime Litigators (IAFCL) and a member of the European Board of the International Association of Independent Corporate Monitors (IAICM). Daniel L. Bühr is also a member of the Swiss Association for Standardization and a member of the Expert Committees on Compliance management systems and on Governance of organizations of the International Organization for Standardization (ISO). He is an accredited ISO Compliance Management System Auditor and co-founder and Honorary Chairman of Ethics and Compliance Switzerland (ECS).
Before joining LALIVE, Daniel L. Bühr was Regional Counsel for a Swiss multinational, responsible for all legal matters in Europe, Russia, the Near East and Africa (2006-2011). During this period, he served as member of the investment committee of Venture Incubator Ltd (a private equity fund of leading Swiss companies). He previously founded and managed a Swiss venture company (2004–2007) and served as Company Secretary and Legal Counsel of a global retail group (1993-2003).
Daniel L. Bühr holds a PhD, summa cum laude, from the University of Berne Institute for Swiss and Foreign Civil Procedure Law and MBA degrees from Columbia University, New York, and London Business School (EMBA Global Programme). He graduated from the University of Berne in 1991 (magna cum laude).
Timothy O'Toole
William Barry
William Barry is a trusted advisor to governments, boards of directors, foreign trustees, multinational companies and senior officers involved in cross-border business and the financial services industry. Mr. Barry helps solve complex problems involving multi-jurisdictional investigations, enforcement, compliance, and transactional issues so that his clients can overcome obstacles and resume focus on their business. He works with clients to address individual risks and to build credible, flexible and sustainable compliance infrastructure consistent with ESG standards.
Mr. Barry guides clients through the complex issues involved in responding to inquiries from domestic and international regulators regarding issues of accounting fraud, foreign bribery, money laundering, and other financial crimes. He represents clients faced with the challenge of responding to competing demands in parallel proceedings, such as internal reviews, government investigations, and private civil actions.
Chambers USA has described Mr. Barry as "the kind of person that everyone in the boardroom listens to" and noted he is "a very thorough thinker and very calm, and is the ideal ambassador for corporations when dealing with government agencies."
Mr. Barry is a member of the American Bar Association's International Anti-Money Laundering (AML) Committee and International Anti-Corruption Committee. He has been designated as a Certified Anti-Money Laundering Specialist by ACAMS, the Association of Certified Anti-Money Laundering Specialists.
Mr. Barry is a member of the Sustainability Accounting Review Board (SASB) Alliance.
Mr. Barry is a member of the Washington Lawyers Committee for Civil Rights and Urban Affairs, and the former Chairman of Olney Boys & Girls Club, a non-profit sports association in Maryland.
Juan Antonio de Lassaletta
Juancho de Lassaletta joined Vifor Fresenius Medical Care Renal Pharma (VFMCRP) in August 2019 as Vice-President & Global Head Legal and Compliance.
Juancho studied law at the University of Barcelona and completed postgraduate studies at IESE Business School, Corporate Development Program (PDD).
He started his career at international law firms working during 14 years as a corporate and M&A lawyer in the life sciences spaces in the Iberian and Latin America markets.
His in-house career, as Associate to General Counsel and Head of Compliance, led him in 2015 to InsudPharma Group (generics) where he led the design and implementation of Insudpharm Global Compliance Program with special focus in Latin America.
At VFMCRP, Juancho is globally responsible for all legal, IP, litigation and compliance matters. Interface to global Fresenius Medical Care legal, IP and compliance teams, member of FMC Legal Leadership Team.
His areas of specialization are most notably BD & License-in deals with US biotechs, M&A and Compliance. He works closely with a diverse range of senior stakeholders at Vifor Pharma’s and FMC’s global headquarters, building effective relationships and driving consensus.
Lashell Robinson
Faizal Nunes
Faizal Nunes is the Deputy Global Head of Anti-Fraud for Credit Suisse based in Zurich where he is responsible for the global 2LoD Anti-Fraud Programme, Framework and Standards covering Investment Banking, Wealth management, Asset Management divisions as well as Corporate functions.
He has significant experience in multi-jurisdictional forensic investigations, enforcement/monitor led compliance remediation projects, regulatory driven initiatives in various industries as well as hands-on experience in emerging markets.
In addition, Faizal has been working on various initiatives related to reviewing the effectiveness of compliance programmes, identifying risk mitigation measures whilst considering business risk appetite, client engagement and process/control simplification. Faizal’s interests also include proactive identification of new and emerging risks such as Crypto as an Asset class, ESG/climate change and Cyber Fraud.
Prior to Credit Suisse, Faizal was an Assistant Director within EY’s forensic practice where he led a wide range of large-scale investigations in fraud, bribery and corruption as well as compliance projects for EY’s global clients.
Steve Young
Alon Garber
Alon Garber, Head of Ethics & Compliance and Group Internal Audit IT, joined Takeda, a patient-focused, values-based, R&D-driven global biopharmaceutical company in 2016.
In his capacity as IT business partner for these two business functions, Alon is working to deliver on strategic programs such as Compliance Monitoring, Audit Automation and Fraud detection using cutting edge technologies.
Prior to Takeda, Alon worked during 13 years at Merck KGaA, a vibrant science and technology company based in Darmstadt, Germany.
Alon is passionate about using technology to address critical business needs, reduce manual efforts and digitalize end-to-end business processes.